KAI-9xxx

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameKAI-9xxx
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C beta modulatorsProtein kinase C delta modulators
TargetsProtein kinase C deltaProtein kinase C beta
Therapy Area/IndicationsSolid tumoursMacular DegenerationDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKai Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKai Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursMacular DegenerationDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksN/A